Making decisions about hormone replacement therapy: Bisphosphonates should not be recommended for women aged 50BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7403.1398-a (Published 19 June 2003) Cite this as: BMJ 2003;326:1398
- Susan M Ott, associate professor (firstname.lastname@example.org)
- University of Washington, 98195 Washington, DC, USA
EDITOR—Many people, including Rymer et al in their clinical review,1 say that bisphosphonates can be used instead of oestrogen to prevent osteoporotic fractures. Clinical trials of bisphosphonates in perimenopausal women have shown …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial